UMR 1030 - Publications

Groupe de Jean Bourhis

• 1. Arriagada R., Bourgier C. Effect of radiation dose on local control in breast cancer.
  Radiother Oncol. 86 : 285-292, 2008.
  
•  2. Boerma M., Fu Q., Wang J., Loose D.S., Bartolozzi A., Ellis J., McGonigle E., Paradise E., Sweetnam P., Fink L.M., Vozenin-Brotons M.C., Hauer-Jensen M. Comparative gene expression profiling in three primary human cell lines after treatment with a novel inhibitor of Rho Kinase or atorvastatin.
  Blood Coagul and Fibrinolysis. 19 : (7) 709-718, 2008.
  
• 3. Haydont V., Riser B.L., Aigueperse J. and Vozenin-Brotons M.C. Specific signals involved in the long-term maintenance of radiation-induced fibrogenic differentiation : a role for CCN2 and low concentration of TGF-β1.
  Am. J. Physiol. Cell. Physiol. 294 : (6) C1332-C1341, 2008.
  
• 4. Mazeron R., Bourhis J., Deutsch E. Angiogenèse et radiothérapie : tout ce qu’un oncologue radiothérapeute doit savoir.
  Cancer/Radiother. 12 : 50-60, 2008.
  
• 5. Milliat F., Sabourin J.C, Tarlet G, Holler V., Deutsch E., Buard V., Tamarat R., Atfi A., Benderitter M. and François A. Essential Role of Plasminogen Activator Inhibitor Type-1 in Radiation Enteropathy.
  The American Journal of Pathology. 172 : (3) 691-701 2008.
  
• 6. Tao Y., Zhang P., Girdler F., Frascogna V., Castedo M., Bourhis J., Kroemer G., Deutsch E. Enhancement of radiation response in p53-deficient cancer cells by the Aurora-B kinase inhibitor AZD1152.
  Oncogene. 27 : (23) 3244-3255, 2008. Epub 2007 Dec 17.
•  7. Vozenin-Brotons M.C., Haydont V. Steps toward strategies to improve normal tissue toxicity.
  Int. J. Radiat. Oncol. Biol. Phys. 72 : (2) 629, 2008.
  
•  8. Wahab M.A., Nickless E.M., Najar-M’Kacher R., Parmentier C., Podd J.V., Rowland R.E. Elevated chromosome translocation frequencies in New Zealand nuclear test veterans.
  Cytogenet Genome Res. 121: (2) 79-87, 2008.

• 1. Amine A., Rivera S., Opolon P., Dekkal M., SF Biard D., Bouamar H., Louache F., Michael J McKay , Bourhis J., Deutsch E and Vozenin-Brotons M.C. Novel anti-metastatic action of Cidofovir mediated by inhibition of E6/E7, CXCR4 and Rho/ROCK signaling in HPV+ tumor cells.
  PLOS one. 4 : (3) e5018, 2009.
  
•  2. Gervaz P, Morel P and Vozenin-Brotons MC. Molecular aspects of intestinal radiation-induced fibrosis.
  Curr Mol Med. 9 : (3) 273-280, 2009.
  
• 3. Maggiorella L., Aubel C., Haton C., Milliat F., Connault E., Opolon P., Deutsch E., Bourhis J. Cooperative effect of roscovitine and irradiation targets angiogenesis and induces vascular destabilization in human breast carcinoma.
  Cell prolif. 42 : (1) 38-48, 2009.
  
• 4. Mangoni M., Yue X., Morin C., Violot D., Frascogna V., Tao Y., Opolon P., Castaing M., Auperin A., Biti G., Barritault D., Vozenin-Brotons M.C., Deutsch E. and Bourhis J. Differential effect triggered by an heparan mimetic of the RGTA® family preventing oral mucositis without tumour protection.
  Int. J. Radiat. Oncol. Biol. Phys. 74 : (4) 1242-1250, 2009.
  
• 5. Mazeron R., Bourhis J., Deutsch E. Angiogenesis inhibitors and radiation therapy : concept and preliminary results.
  Bull Cancer. 96 : (3) 299-310, 2009.
  
•  6. Tao Y., Leteur C., Yang C., Zhang P., Castedo M., Pierré A., M. Golsteyn R., Bourhis J., Kroemer G. and Deutsch E. Radiosensitization by Chir-124, a selective CHK1 inhibitor. Effects of p53 and cell cycle checkpoints.
  Cell Cycle. 8 : (8) 1196-1205, 2009.
  
•  7. Tao Y., Leteur C., Calderaro J., Girdler F., Zhang P., Frascogna V., Varna M., Opolon P., Castedo M., Bourhis J., Kroemer G and Deutsch E. The Aurora B kinase inhibitor AZD1152 sensitizes cancer cells to fractionated irradiation and induces mitotic catastrophe.
  Cell Cycle. 8 : (19) 3172-3181, 2009.
  
• 8. Vozenin-Brotons M.C., Deutsch E. Radiosensitivity of human papillomavirus related tumors : in regard to gupta et al.
  Int. J. Radiat. Oncol. Biol. Phys. 74 : 928-933, 2009.

• 1. Bourgier C., Vozenin M.C. and Deutsch E. Réirradiation des tissues sains : données radiobiologiques précliniques.
  Cancer/Radiother. Oct ; 14 (6-7) 412-415, 2010.
  
• 2. Loriot Y., Calderaro J., Soria J.C., Deutsch E., Vielh P. Mécanismes anti-apoptotiques dans le carcinome à petites cellules du poumon.
  Ann. Pathol. 30 : (1) 17-24, 2010.
  
• 3. Loriot Y., Mordant P., Dorvault N., De la Motte Rouge T., Bourhis J., Soria J.C., Deutsch E. BMS-690514, a VEGFR and EGFR tyrosine kinase inhibitor shows antitumoral activity on non-small lung cancer xenografts and induces sequence-dependent synergistic effect with radiation.
  Br. J. Cancer. Jul 27, 103 : (3) : 347-353, 2010.
  
• 4. M’Kacher R., Andreoletti L., Flamant S., Milliat F., Girinsky T., Dossou J., Violot D., Assaf E., Clausse B., Koscielny S., Bourhis J., Bosq J., Bernheim A., Parmentier C., and Carde P. JC human polyomavirus is associated to chromosomal instability in peripheral blood lymphocytes of Hodgkin’s lymphoma patients and poor clinical outcome.
  Ann.Oncol. apr 21 : (4) 826-832, 2010. octobre 13, epub 2009.
  
• 5. Monceau V., Pasinetti N., Schupp C., Pouzoulet F., Opolon P and Vozenin M.C. Modulation of the Rho/ROCK pathway in heart and lung after thorax irradiation reveals targets to improve normal tissue toxicity.
  Current Drug target. nov 1; 11 (11) : 1395-1404, 2010.
  
• 6. Mordant P., Loriot Y., Leteur C., Calderaro J., Bourhis J., Wislez M., Soria J.C., Deutsch E. Dependence on phosphoinositide 3-kinase and RAS-RAF pathways drive the activity of RAF265, a novel RAF/VEGFR2 inhibitor, and RAD001 (Everolimus) in combination.
  Mol. Cancer. Ther. 9 : (2) 358-368, 2010.
  
• 7. Mordant P., Loriot Y., Castier Y., Deutsch E. Concordance between epidermal growth factor receptor status in primary non-small-cell lung cancer and metastases : still to be established.
  Eur J Cardiothorac Surg. 2010 Jul 26.
  
• 8. Stuelsatz P., Pouzoulet F., Lamarre Y., Dargelos E., Poussard S., Leibovitch S., Cottin P., Veschambre P. Down-regulation of myod by calpain 3 promotes generation of reserve cells in c2c12 myoblasts.
  J. Biol. Chem. 285 : (17) 12670-12683, 2010.
  
• 9. Veres C., Garsi J.P., Rubino C., Pouzoulet F., Bidault F;, Chavaudra J., Bridier A., Ricard M., Ferreira I., Lefkopoulos D., De Vathaire F., Diallo I. Thyroid volume measurement in external beam radiotherapy patients using CT imaging : correlation with clinical and anthropometric characteristics.
  Phys. Med. Biol. 55 : N507-N519, 2010.
  
• 10. Vozenin M.C., Lord H.K., Hartl D., Deutsch E. Unravelling the biology of human papillomavirus (HPV) related tumours in order to enhance their radiosensitivity .
  Cancer Treatment Review, 2010 en revision favorable.
  
• 11. Vozenin M.C., Bourhis J., Deutsch E. What have we learned from human papillomavirus-positive tumors ? Trying to connect data about biomarkers among human papillomavirus-related squamous cell carcinomas.
  J. Clin. Oncol. 28 : (20) 340-341, 2010.

• Yarnold Y. and Vozenin Brotons M.C. Pathogenic mechanisms in radiation fibrosis.
  Radiother&Oncol, 2010, en revision favorable.
  
• Roch-Lefevre S., Pouzoulet F., Giraudet A.L., Voisin P., Vaurijoux A., Gruel G., Gregoire E., Buard V. Delbos M., Voisin P., Bourhis J., Roy L. Cytogenetic assessment of heterogeneous radiation doses in cancer patients treated with fractionated radiotherapy.
  Br. J. R.